VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 103 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 6.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 150 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | -33.3% | 150 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | -62.5% | 150 | -62.5% | 0.00% | -100.0% |
| Q1 2019 | $8,000 | +33.3% | 400 | -38.5% | 0.00% | – |
| Q4 2018 | $6,000 | -50.0% | 650 | 0.0% | 0.00% | – |
| Q3 2018 | $12,000 | -7.7% | 650 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $13,000 | +8.3% | 650 | -13.3% | 0.00% | 0.0% |
| Q1 2018 | $12,000 | 0.0% | 750 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $12,000 | -7.7% | 750 | +15.4% | 0.00% | 0.0% |
| Q3 2017 | $13,000 | +62.5% | 650 | +62.5% | 0.00% | 0.0% |
| Q1 2016 | $8,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $109,992,000 | 62.32% |
| Foresite Capital Management IV, LLC | 830,565 | $14,294,000 | 4.62% |
| Casdin Capital, LLC | 1,128,075 | $19,414,171,000 | 2.01% |
| ARMISTICE CAPITAL, LLC | 1,096,000 | $18,862,000 | 1.25% |
| Bellevue Group AG | 2,704,683 | $46,548,000 | 0.87% |
| PFM Health Sciences, LP | 1,231,954 | $21,202,000 | 0.63% |
| Boxer Capital, LLC | 500,000 | $8,605,000 | 0.62% |
| Aevitas Wealth Management, Inc. | 23,150 | $398,000 | 0.40% |
| 361 CAPITAL LLC | 120,143 | $2,068,000 | 0.38% |
| Birchview Capital, LP | 30,000 | $516,000 | 0.34% |